Table 1 Changes in laboratory parameters during the hospitalization
| Â | 2019-7-1 | 2019-7-16 | 2019-7-31 | Reference range |
|---|---|---|---|---|
WBC (109/L) | 2.65 | 3.22 | 2.47 | 4 ~ 10 |
NEU(109/L) | 1.16 | 1.99 | 1.59 | 2 ~ 8 |
LYM (109/L) | 1.25 | 1.02 | 0.62 | 1 ~ 5 |
MON (109/L) | 0.05 | 0.18 | 0.25 | 0.2 ~ 0.8 |
EO (109/L) | 0.01 | 0.02 | 0 | 0.02 ~ 0.5 |
BASO (109/L) | 0.18 | 0.01 | 0.01 | 0 ~ 0.1 |
Hb (g/L) | 112 | 27.76 | 116 | 110 ~ 150 |
PLT (109/L) | 136 | 191.5 | 151.5 | 100 ~ 300 |
ALT (U/L) | 40.8 | 18.9 | 23.6 | 7 ~ 40 |
AST (U/L) | 54.6 | 25.2 | 38.6 | 13 ~ 35 |
TBIL (μmol/L) | 10.2 | 9.3 | 10 | 0 ~ 18.8 |
DBIL (μmol/L) | 4.8 | 3.1 | 3.5 | 0 ~ 6.8 |
TP (g/L) | 70.2 | 71.2 | 70.8 | 65 ~ 85 |
ALB (g/L) | 39.4 | 41.1 | 40.9 | 40 ~ 55 |
ALP (U/L) | 148 | 135.2 | 138.2 | 35 ~ 100 |
GGT (U/L) | 9059 | 9891 | 8801 | 7 ~ 45 |
TBA (μmol/L) | 4 | 3.5 | 4.4 | 0 ~ 10 |
sCr (μmol/L) | 175 | 297 | 177 | 41 ~ 73 |
LDH (U/L) | 282.6 | 202.4 | 209.3 | 120 ~ 250 |
The antinuclear antibody | 1:1000 | NA | NA | < 1:100 |
Ferritin (ng/ml) | 32.2 | NA | NA | 11 ~ 306.8 |
T lymphocytes/ lymphocytes (%) | 93.34 | NA | NA | 56 ~ 85 |
T lymphocytes (cells/UL) | 1365 | NA | NA | 1027 ~ 2086 |
CD4+ T lymphocytes/ T lymphocytes (%) | 25.56 | NA | NA | 30 ~ 54 |
CD4+ T lymphocytes (cells/UL) | 359 | NA | NA | 706 ~ 1125 |
CD4+ T lymphocytes/ T lymphocytes (%) | 24.25 | NA | NA | 15 ~ 34 |
CD8+ T lymphocytes (cells/UL) | 340 | NA | NA | 320 ~ 1250 |
CD4+ T lymphocytes/ CD8+ T lymphocytes (%) | 0.95 | NA | NA | 1 ~ 2 |
Natural killer cells (cells/UL) | 16 | NA | NA | 90 ~ 590 |
B lymphocytes (cells/UL) | 18 | NA | NA | 90 ~ 660 |
EB virus nucleic acida (copies/ml) | 3.33 × 107 | 2.92 × 107 | 4.55 × 104 | 4 × 102 |
EB virus nucleic acidb (copies/ml) | NA | NA | < 4 × 102 | 4 × 102 |